Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest show of support for weight-loss drugs as he has pushed for making them more accessible to the general public.

CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic. Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s,

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.

This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa Suit on a photo posted to X, The Tesla founder indicates he’s taking one of the widely popular weight loss drugs,

Elon Musk posted a photo with the caption "Ozempic Santa" and revealed that he's taking Mounjaro for weight loss. Musk, who Donald Trump appointed to advise him on cutting government spending, has struggled with his weight.

Elon Musk recently shared a post on X, revealing he uses the weight loss drug Mounjaro. Musk posed in a Santa Claus outfit by a holiday tree and captioned the post, "Ozempic Santa," later clarifying he uses Mounjaro.

Elon Musk has revealed he has switched to a more powerful weight-loss drug, sharing the news alongside a photo of himself dressed as Father Christmas. The SpaceX billionaire, 53, posted a picture of himself slimmed down in a red-and-white fur-lined suit with the caption: "Ozempic Santa".